A Significant Reduction in the Plasma Levels and Gene Expression of CCL2 in Patients with Osteoarthritis Following Intervention with Krocina™

Overview

Journal Rep Biochem Mol Biol

Specialty Biochemistry

Date 2022 Jun 29

PMID 35765531

Authors

Samaneh Beiki

Jalil Tavakkol-Afshari

Zhaleh Shariati-Sarabi

Javad Poursamimi

Arezoo Gowhari Shabgah

Mojgan Mohammadi

Affiliations

Soon will be listed here.

Abstract

Background: inflammatory chemokines such as CCL2 and CCL5 are involved in the progress of osteoarthritis. Crocin with antioxidant and anti-inflammatory properties can reduce the symptoms of osteoarthritis (OA). This study was performed investigate the effect of Krocina™, on the gene expressions and plasma levels of CCL2 and CCL5 in OA patients.

Methods: The study included 35 patients that were randomized in the Krocina™ and placebo groups. The intervention was Krocina™ 15mg daily for four months. Clinical and paraclinical parameters were measured. CCL2 and CCL5 genes expression and plasma levels were determined using the SYBR Green Real-Time RT-PCR and Enzyme-linked Immunosorbent Assay (ELISA) techniques.

Results: The C-reactive protein (CRP) value in the Krocina™ group and the visual analogue scale (VAS) value in the Krocina™ and placebo groups decreased significantly after the intervention. The gene expression of CCL2 in the Krocina™ and placebo groups decreased significantly. On the contrary, the gene expression of CCL5 in the Krocina™ and placebo groups increased significantly. Moreover, the plasma levels of CCL2 in the Krocina™ and placebo groups decreased meaningfully. There was no difference regarding the plasma levels of CCL5 within the Krocina™ and placebo groups before and after the intervention in either of the groups.

Conclusion: Administration of Krocina™ reduced the clinical signs of inflammation and CRP and VAS value. Also, Krocina™ significantly decreased the plasma levels and gene expression of CCL2 in osteoarthritis patients.

Citing Articles

The effect of crocin on cholestasis-induced spatial memory impairment with respect to the expression level of TFAM and PGC-1α and activity of catalase and superoxide dismutase in the hippocampus.

Mehrabanifar S, Hesami-Tackallou S, Vaseghi S, Nasehi M Metab Brain Dis. 2023; 38(4):1167-1176.

PMID: 36807082 DOI: 10.1007/s11011-023-01176-9.

References

Jiang S, Lu J, Deng Z, Li Y, Lei G . Long noncoding RNAs in osteoarthritis. Joint Bone Spine. 2016; 84(5):553-556. DOI: 10.1016/j.jbspin.2016.09.006. View

Zhang H, Guan Z, Guan S, Yang K, Pan Y, Wu Y . Identification of Suitable Candidate Reference Genes for Gene Expression Analysis by RT-qPCR in Peripheral Blood Mononuclear Cells of CHB Patients. Clin Lab. 2016; 62(1-2):227-34. DOI: 10.7754/clin.lab.2015.150805. View

Hsu Y, Hsieh M, Liang Y, Li C, Sheu M, Chou D . Production of the chemokine eotaxin-1 in osteoarthritis and its role in cartilage degradation. J Cell Biochem. 2004; 93(5):929-39. DOI: 10.1002/jcb.20239. View

Robinson W, Lepus C, Wang Q, Raghu H, Mao R, Lindstrom T . Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016; 12(10):580-92. PMC: 5500215. DOI: 10.1038/nrrheum.2016.136. View

Yuan G, Masuko-Hongo K, Sakata M, Tsuruha J, Onuma H, Nakamura H . The role of C-C chemokines and their receptors in osteoarthritis. Arthritis Rheum. 2001; 44(5):1056-70. DOI: 10.1002/1529-0131(200105)44:5<1056::AID-ANR186>3.0.CO;2-U. View

Lei M, Guo C, Hua L, Xue S, Yu D, Zhang C . Crocin Attenuates Joint Pain and Muscle Dysfunction in Osteoarthritis Rat. Inflammation. 2017; 40(6):2086-2093. DOI: 10.1007/s10753-017-0648-8. View

Yang R, Yang L, Shen X, Cheng W, Zhao B, Ali K . Suppression of NF-κB pathway by crocetin contributes to attenuation of lipopolysaccharide-induced acute lung injury in mice. Eur J Pharmacol. 2011; 674(2-3):391-6. DOI: 10.1016/j.ejphar.2011.08.029. View

Miller R, Tran P, Das R, Ghoreishi-Haack N, Ren D, Miller R . CCR2 chemokine receptor signaling mediates pain in experimental osteoarthritis. Proc Natl Acad Sci U S A. 2012; 109(50):20602-7. PMC: 3528555. DOI: 10.1073/pnas.1209294110. View

Zhang W, Robertson J, Jones A, Dieppe P, Doherty M . The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis. 2008; 67(12):1716-23. DOI: 10.1136/ard.2008.092015. View

10.

Mohammadi A, Balizadeh Karami A, Mard S, Goudarzi G, Maleki H, Chamkouri N . Effect of Total Suspended Particulate Matter in the Air on Inflammation Factors and Apoptotic Markers in Diabetic Rats: The Protective Effect of Insulin and Crocin. Rep Biochem Mol Biol. 2021; 10(2):334-345. PMC: 8480286. DOI: 10.52547/rbmb.10.2.334. View

11.

Nguyen L, Sharma A, Chakraborty C, Saibaba B, Ahn M, Lee S . Review of Prospects of Biological Fluid Biomarkers in Osteoarthritis. Int J Mol Sci. 2017; 18(3). PMC: 5372617. DOI: 10.3390/ijms18030601. View

12.

Alaaeddine N, Olee T, Hashimoto S, Lotz M . Production of the chemokine RANTES by articular chondrocytes and role in cartilage degradation. Arthritis Rheum. 2001; 44(7):1633-43. DOI: 10.1002/1529-0131(200107)44:7<1633::AID-ART286>3.0.CO;2-Z. View

13.

Alavizadeh S, Hosseinzadeh H . Bioactivity assessment and toxicity of crocin: a comprehensive review. Food Chem Toxicol. 2013; 64:65-80. DOI: 10.1016/j.fct.2013.11.016. View

14.

Kim K, Lee H, Lim S . Effects of increased standing balance on pain in patients with knee osteoarthritis. J Phys Ther Sci. 2016; 28(1):87-9. PMC: 4755980. DOI: 10.1589/jpts.28.87. View

15.

Sohan Forooshan Moghadam A, Ataei M, Arabzadeh G, Falahati K, Roshani F, Sanati M . Analysis of Expression in Multiple Sclerosis Patients. Rep Biochem Mol Biol. 2020; 8(4):429-437. PMC: 7275836. View

16.

Mollazadeh H, Emami S, Hosseinzadeh H . Razi's Al-Hawi and saffron (Crocus sativus): a review. Iran J Basic Med Sci. 2016; 18(12):1153-66. PMC: 4744354. View

17.

Wampold B, Minami T, Tierney S, Baskin T, Bhati K . The placebo is powerful: estimating placebo effects in medicine and psychotherapy from randomized clinical trials. J Clin Psychol. 2005; 61(7):835-54. DOI: 10.1002/jclp.20129. View

18.

Taruc-Uy R, Lynch S . Diagnosis and treatment of osteoarthritis. Prim Care. 2013; 40(4):821-36, vii. DOI: 10.1016/j.pop.2013.08.003. View

19.

Ding Q, Zhong H, Qi Y, Cheng Y, Li W, Yan S . Anti-arthritic effects of crocin in interleukin-1β-treated articular chondrocytes and cartilage in a rabbit osteoarthritic model. Inflamm Res. 2012; 62(1):17-25. DOI: 10.1007/s00011-012-0546-3. View

20.

Li Y, Kakkar R, Wang J . and Approach to Anti-arthritic and Anti-inflammatory Effect of Crocetin by Alteration of Nuclear Factor-E2-Related Factor 2/hem Oxygenase (HO)-1 and NF-κB Expression. Front Pharmacol. 2019; 9:1341. PMC: 6299880. DOI: 10.3389/fphar.2018.01341. View